CFO4Life Group’s Chemours CC Stock Holding History

CFO4Life Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,332	Closed	-$210K	–	122
2018 Q3	$210K	Sell	5,332 -5,977	-53%	-$262K	0.09%	120
2018 Q2	$502K	Buy	11,309 +3,961	+54%	+$197K	0.21%	74
2018 Q1	$358K	Buy	7,348 +1,893	+35%	+$94.6K	0.3%	57
2017 Q4	$273K	Buy	5,455 +71	+1%	+$3.72K	0.21%	78
2017 Q3	$272K	Buy	+5,384	New	+$254K	0.22%	82

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

CFO4Life Group's CC Position: Q4 2018 in Review

CFO4Life Group sold out of Chemours (CC) in Q4 2018, closing a stake of 5,332 shares — an estimated $210K sold.

CFO4Life Group first reported a position in CC in Q3 2017 and held it in 5 quarters. The position peaked at $502K in Q2 2018. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

CFO4Life Group reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
CFO4Life Group sold 5,332 Chemours shares in Q4 2018, an estimated $210K.
CFO4Life Group first reported a position in Chemours in Q3 2017 and held it in 5 quarters.
CFO4Life Group's Chemours position peaked at $502K in Q2 2018.
506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on CFO4Life Group's 13F filing for Q4 2018, filed 1 Feb 2019.